Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Conservative management of endometrial intraepithelial neoplasia in a patient with cirrhosis undergoing orthotopic liver transplant

Morgan, Jessica MD; Hinz, Erica K. MD, MPH

doi: 10.1097/GME.0000000000001342
Case Report

Objective: The aim of the study was to review the management of endometrial hyperplasia in a woman undergoing liver transplantation for alcoholic cirrhosis.

Methods: This is a case presentation on a postmenopausal woman with a tissue diagnosis of endometrial intraepithelial neoplasia managed with a levonorgestrel intrauterine device, before and after liver transplantation. Full written informed consent was obtained from the patient to present her case.

Results: The patient experienced resolution of her endometrial intraepithelial neoplasia with conversion to atrophic endometrium after management with levonorgestrel intrauterine device.

Conclusions: A large percentage of women with cirrhosis experience abnormal uterine bleeding, which may be due to the coagulopathy that accompanies liver disease, or endometrial hyperplasia or carcinoma. Although hysterectomy is the criterion standard of treatment for atypical endometrial hyperplasia in a postmenopausal woman, patients with cirrhosis severe enough to require transplant are usually poor surgical candidates. Multiple studies have shown success with conservative management of atypical hyperplasia. There is a paucity of literature on managing patients undergoing transplant with abnormal uterine bleeding and it is therefore important to highlight conservative management options for this patient population.

Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL.

Address correspondence to: Jessica Morgan, MD, Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, 820 South Wood St, MC 808, Chicago, IL 60612. E-mail:

Received 5 February, 2019

Revised 12 March, 2019

Accepted 12 March, 2019

Funding/support: None reported.

Financial disclosure/conflicts of interest: None reported.

Online date: April 15, 2019

© 2019 by The North American Menopause Society.